Delivery Order SPE2DB24D2212-SPE2DB25FHPQU

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,259.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication AZSTARYS 39.2 MG-7.8 MG CAP 100S, with a completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,096.07, is a firm fixed-price delivery order for AZSTARYS CAPS 52.3MG/10.4MG. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $2,941.40 and a completion date of May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ07S, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.37 firm fixed price delivery order is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,531.52 and an ultimate completion date of March 17, 2025. It is a delivery order contract for the supply of pharmaceutical products, including AZSTARYS capsules, with a firm fixed price pricing type. The contract is not designated as a set-aside....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a prescription medication. The contract has a ceiling value of $1,156.16 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FREJ6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,613.20 and an ultimate completion date of March 14, 2025. The contract covers the procurement of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product. This award is...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,169.97 contract is for the supply of AZSTARYS capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,185.65 firm fixed-price contract has an ultimate completion date of April 22, 2025 and is not designated as a set-aside. Amerisourcebergen, the prime contractor, will provide a range of pharmaceutical products and medical supplies to support military healthcare programs worldwide under this delivery order,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $1,455.84 and a performance period ending on April 7, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPQU
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,983.06, is for the supply of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. The contract is part of a larger Indefinite Delivery Contract (IDC) vehicle, SPE2DX, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support to the DLA, the Defense Health Agency, U.S. Coast Guard, and other government agencies. This IDC contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen Drug Corp as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/3/25, 12:44 AM